Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.000
+0.044 (4.62%)
At close: Nov 20, 2024, 4:00 PM
1.030
+0.030 (3.00%)
After-hours: Nov 20, 2024, 7:44 PM EST
Lucid Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 4.19 | 2.43 | 0.38 | 0.5 | - | - | |
Revenue Growth (YoY) | 179.27% | 544.03% | -24.60% | - | - | - | |
Cost of Revenue | 6.41 | 5.98 | 3.61 | 0.59 | - | - | |
Gross Profit | -2.22 | -3.55 | -3.24 | -0.09 | - | - | |
Selling, General & Admin | 35.36 | 35.66 | 40.11 | 18.04 | 2.84 | 0.96 | |
Research & Development | 6.46 | 7.25 | 11.26 | 9.3 | 5.44 | 3.46 | |
Operating Expenses | 42.91 | 44.93 | 53.01 | 27.33 | 8.28 | 4.42 | |
Operating Income | -45.13 | -48.48 | -56.25 | -27.42 | -8.28 | -4.42 | |
Interest Expense | -0.03 | -0.42 | -0.01 | -0.66 | - | - | |
Interest & Investment Income | 0.35 | 0.42 | 0.09 | - | - | - | |
Other Non Operating Income (Expenses) | - | -1.19 | - | - | - | - | |
EBT Excluding Unusual Items | -44.81 | -49.66 | -56.17 | -28.08 | -8.28 | -4.42 | |
Other Unusual Items | -0.01 | -3.01 | - | - | - | - | |
Pretax Income | -44.82 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | |
Net Income | -44.82 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | |
Net Income to Common | -52.31 | -52.67 | -56.17 | -28.08 | -8.28 | -4.42 | |
Shares Outstanding (Basic) | 46 | 42 | 36 | 19 | 14 | 14 | |
Shares Outstanding (Diluted) | 46 | 42 | 36 | 19 | 14 | 14 | |
Shares Change (YoY) | 14.76% | 15.44% | 94.44% | 31.81% | 0.03% | - | |
EPS (Basic) | -1.13 | -1.26 | -1.55 | -1.51 | -0.59 | -0.31 | |
EPS (Diluted) | -1.13 | -1.26 | -1.55 | -1.51 | -0.59 | -0.31 | |
Free Cash Flow | -44.46 | -33.04 | -30.59 | -18.53 | -5.63 | -2.36 | |
Free Cash Flow Per Share | -0.96 | -0.79 | -0.85 | -1.00 | -0.40 | -0.17 | |
Gross Margin | -53.07% | -146.25% | - | -17.00% | - | - | |
Operating Margin | -1077.37% | -1996.79% | -14920.69% | -5483.80% | - | - | |
Profit Margin | -1248.84% | -2169.11% | -14899.47% | -5615.60% | - | - | |
Free Cash Flow Margin | -1061.35% | -1360.71% | -8114.85% | -3706.00% | - | - | |
EBITDA | -43.56 | -45.98 | -54.32 | -27.42 | - | - | |
D&A For EBITDA | 1.57 | 2.5 | 1.94 | 0 | - | - | |
EBIT | -45.13 | -48.48 | -56.25 | -27.42 | -8.28 | -4.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.